+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pre-Clinical CROs Market to 2027 - Global Analysis and Forecasts By Service; End User, and Geography

  • ID: 4847182
  • Report
  • Region: Global
  • 139 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2020
1 of 3

FEATURED COMPANIES

  • Charles River
  • Covance, Inc.
  • Eurofins Scientific
  • ICON Plc
  • MD Biosciences
  • Medpace, Inc.
  • MORE
The global pre-clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.42 Mn in 2018. The pre-clinical CROs market is estimated to grow with a CAGR of 8.1% from 2019-2027.

The market is driven by factors such as, increasing R&D expenditures and higher cost of drug development process in developed countries. However, dearth of skilled professionals may limit the growth of the market to a certain extent.

Increasing R&D expenditures made by the companies has been driving the growth of the pre-clinical CROs market. Research & development (R&D) is a significant and essential part of a company’s business. Pharmaceutical and biotech companies majorly focus on research and development (R&D) to come up with new molecules for various therapeutic applications with the most significant medical and commercial potential. The companies invest majorly on the R&Ds intending to deliver high quality and innovative products to the market. R&D investments made by biopharmaceutical companies has increased over the years. As per a report published by Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion in 2012 to US$ 58.8 billion in 2015. R&D not only leads to huge investment but also leads to the involvement of several years. The process from early detection or design to development to regulatory approval can take more than 10 to 15 years. Throughout the development phase of a drug substance, various testing services are required to check the quality and efficacy of the product. Hence, the pharmaceutical and biotech companies prefer to outsource the services to the contract research organizations (CROs) to save the cost and time, which is expected to drive the growth of the market.

Global pre-clinical CROs were segmented by service and end user. Based on the service segment, the market is categorized as, bio-analysis & DMPK studies, toxicology, and other services. On the basis of end user, the market is classified as, biopharmaceutical companies, government & academic institutes, and medical device companies.

Some of the major primary and secondary sources included in the report include, World Health Organization, Association of Clinical Research Organization, European Federation of Pharmaceutical Industries and Associations, European CRO Federation, and Pharmaceutical Research and Manufacturers of America, among others.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pre-clinical CROs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global pre-clinical CROs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Charles River
  • Covance, Inc.
  • Eurofins Scientific
  • ICON Plc
  • MD Biosciences
  • Medpace, Inc.
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Pre-Clinical CROs Market - By Service
1.3.2 Global Pre-Clinical CROs Market - By End User
1.3.3 Global Pre-Clinical CROs Market - By Geography

2. Global Pre-Clinical CROs Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Pre-Clinical CROs Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions

5. Global Pre-Clinical CROs Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing R&D Expenditures
5.1.2 Higher Cost of Drug Development Process in Developed Countries
5.2 Key Market Restraint
5.2.1 Dearth of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Rising Biosimilars and Biologics Market
5.4 Future Trends
5.4.1 Increasing Number of Clinical Trials
5.5 Impact Analysis

6. Pre-Clinical CROs Market - Global Analysis
6.1 Global Pre-Clinical CROs Market Revenue Forecasts And Analysis
6.2 Global Pre-Clinical CROs Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players

7. Global Pre-Clinical CROs Market Analysis- by Service
7.1 Overview
7.2 Global Pre-Clinical CROs Market, By Service 2018 & 2027 (%)
7.3 Bio-Analysis and DMPK Studies Market
7.3.1 Overview
7.3.2 Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 Toxicology Market
7.3.3.1 Overview
7.3.3.2 Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Other Services Market
7.3.4.1 Overview
7.3.4.2 Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Pre-Clinical CROs Market Analysis - by End User
8.1 Overview
8.2 Global Pre-Clinical CROs Market, By End User 2018 & 2027 (%)
8.3 Biopharmaceutical Companies Market
8.3.1 Overview
8.3.2 Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Government & Academic Institutes Market
8.4.1 Overview
8.4.2 Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Medical Device Companies Market
8.5.1 Overview
8.5.2 Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9. Pre-Clinical CROs Market Revenue and Forecasts to 2027 - Geographical Analysis
9.1 North America Pre-Clinical CROs Market
9.1.1 Overview
9.1.2 North America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.3 North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.1.4 North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.5 North America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
9.1.6 US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.1.6.3 US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.1.7.3 Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.1.8.3 Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2 Europe Pre-Clinical CROs Market
9.2.1 Overview
9.2.2 Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.3 Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.2.4 Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.5 Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
9.2.6 UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.2 UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.2.6.3 UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.7 Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.2 Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.2.7.3 Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.8 France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.1 France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.2 France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.2.8.3 France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.9 Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.2 Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.2.9.3 Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.10 Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.1 Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.2 Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.2.10.3 Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3 Asia Pacific Pre-Clinical CROs Market
9.3.1 Overview
9.3.2 Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3 Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.3.4 Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.5 Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
9.3.6 China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.1 China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.2 China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.3.6.3 China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.7 India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.1 India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.2 India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.3.7.3 India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.8 Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.1 Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.2 Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.3.8.3 Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.9 Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.1 Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.2 Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.3.9.3 Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.10 South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.1 South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.2 South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.3.10.3 South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Middle East & Africa Pre-Clinical CROs Market
9.4.1 Overview
9.4.2 Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.3 Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.4.4 Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4.5 Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
9.4.6 South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.1 South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.2 South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.4.6.3 South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4.7 Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.1 Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.2 Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.4.7.3 Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4.8 UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.1 UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.2 UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.4.8.3 UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5 South And Central America Pre-Clinical CROs Market
9.5.1 Overview
9.5.2 South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.3 South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.5.4 South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5.5 South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)
9.5.6 Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.1 Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.2 Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.5.6.3 Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5.7 Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.1 Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.2 Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)
9.5.7.3 Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10. Pre-Clinical CROs Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Pre-Clinical CROs Market, 2016-2019
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)
10.4.1 Expansion & Other Activities
10.4.1.1 Recent Expansion & Other Activities By Players In The Pre-Clinical CROs Market
10.4.2 Product Launches
10.4.2.1 Recent Product Launches By Players In The Pre-Clinical CROs Market
10.5 Inorganic Growth Strategies
10.5.1 Overview
10.6 Inorganic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)
10.6.1 Acquisitions
10.6.1.1 Recent Acquisitions By Players In The Pre-Clinical CROs Market
10.6.2 Agreements & Collaborations
10.6.2.1 Recent Agreements & Collaborations By Players In The Pre-Clinical CROs Market
10.6.3 Partnerships
10.6.3.1 Recent Partnerships By Players In The Pre-clinical CROs Market

11. Pre-Clinical CROs Market-Key Company Profiles
11.1 MD Biosciences, Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Services Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 WuXi AppTec
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Service Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Pharmaceutical Product Development, LLC.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Service Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Covance Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Information
11.4.4 Service Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Charles River
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Services Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 PRA Health Sciences, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Service Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Medpace
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Service Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Parexel International Corporation
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Service Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 ICON Plc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Service Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Eurofins Scientific
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix
12.1 About The Publisher
12.2 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Covance, Inc.
  • Charles River
  • Eurofins Scientific
  • PRA Health Sciences
  • WuXi AppTec
  • Medpace, Inc.
  • Pharmaceutical Product Development, LLC
  • Parexel International Corporation
  • ICON Plc
  • MD Biosciences
Note: Product cover images may vary from those shown
Adroll
adroll